Skip to the page

Data / Form D filings / MedArrive Inc.

MedArrive Inc.: Form D filings

MedArrive Inc., a health care company in New York, NY, filed 2 Form D notices with the SEC between 2022 and 2023. The latest, on April 11, 2023, reports $8 million sold of a $10 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
85 5TH AVE 8TH FLOOR, New York, NY, 10003
Phone
(888) 441-4382
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2018
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(c)
SEC identifier (CIK)
1901894

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 11, 2023New notice$10,000,000$8,000,000$2,000,0001Mar 31, 2023sec.gov
Feb 11, 2022New notice$32,846,769$32,843,775$2,99441Jan 28, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Agneta BreitensteinDirector
Inna PlumbExecutive Officer
William SullivanDirector
Annie CaseDirector
Daniel TrigubExecutive Officer, Director
Andy HarrisonDirector

Other health care companies in New York that filed recently

Every Form D from the week of Apr 10, 2023 · All recent filings in New York · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what MedArrive Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.